K. Agiannitopoulos Et Al. , "Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing," Cancer genomics & proteomics , vol.20, no.5, pp.448-455, 2023
Agiannitopoulos, K. Et Al. 2023. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing. Cancer genomics & proteomics , vol.20, no.5 , 448-455.
Agiannitopoulos, K., Pepe, G., Tsaousis, G. N., Potska, K., Bouzarelou, D., Katseli, A., ... Ntogka, C.(2023). Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing. Cancer genomics & proteomics , vol.20, no.5, 448-455.
Agiannitopoulos, Konstantinos Et Al. "Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing," Cancer genomics & proteomics , vol.20, no.5, 448-455, 2023
Agiannitopoulos, Konstantinos Et Al. "Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing." Cancer genomics & proteomics , vol.20, no.5, pp.448-455, 2023
Agiannitopoulos, K. Et Al. (2023) . "Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing." Cancer genomics & proteomics , vol.20, no.5, pp.448-455.
@article{article, author={Konstantinos Agiannitopoulos Et Al. }, title={Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing}, journal={Cancer genomics & proteomics}, year=2023, pages={448-455} }